CAS 1118-15-6: 1,1,3,3-Tetramethyl-1,3-disiloxanediol

1,1,3,3-Tetramethyldisiloxane-1,3-diol is a chemical compound with the formula (CH(SiO)H). It is a liquid that is soluble in organic solvents. It has been used as a phase-transfer catalyst in clinical research for proliferative diabetic retinopathy. 1,1,3,3-Tetramethyldisiloxane-1,3-diol has been shown to be an efficient plasma mass spectrometry probe for covid-19 pandemic. This chemical compound has also been found to be an effective treatment against prostate cancer cells due to its ring opening and hydrogen chloride catalytic properties. 1,1,3,3-Tetramethyldisiloxane-1,3-diol is synthesized from tetramethyldisiloxane and methanol using acid as a catalyst. The main functional groups of this molecule are